Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Commercial, Reimbursement Hurdles Need To Be Addressed By Antimicrobial Resistance Efforts

Executive Summary

Melinta describes difficulties launching its new antibiotics at BIO CEO & Investor Conference; companies and other stakeholders urge Congress to enact package of incentives to reinvigorate antibiotic pipeline.


Related Content

Antibiotic Incentives: Advocates Sounding The Alarm For DISARM
Finance Watch: Alphamab's $100m Series A Continues Theme Of Big Investments In China Biopharma
Finance Watch: Investment In Novel Antibacterials Gets A New Boost With Qpex Launch
REPAIR Is Trying To Fix The Antibiotic Gap Left By Industry
"Site License" Reimbursement Model For Limited Use Antibacterials Being Explored By US FDA, CMS
Achaogen Questioning Whether Others Will Pursue LPAD Pathway After Zemdri Misses Out
New Report Calls For Pushing And Pulling In Global Fight Against Superbugs
Melinta: A Pure-Play Antibiotics Specialist Rises
Antimicrobial Resistance: Billions Needed To Encourage New Drugs
How To Spur Antibiotic Development? Higher Reimbursement, Govt. Funding Proposed By PCAST


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts